RhumbLine Advisers
TNON icon

RhumbLine Advisers’s Tenon Medical TNON Stock Holding History

RhumbLine Advisers’s Portfolio TNON Stock Details TNON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-30
Closed -$652 – 4357
2023
Q2 		$652 Buy
+30
New +$3.15K ﹤0.01% 4309

Other funds holding TNON

TWM
TMD Wealth Management Scottsdale, Arizona $456M AUM 11.92% 1-Year Est. Return
SAMC
Spectrum Asset Management (California) Newport Beach, California $360M AUM 19.03% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RhumbLine Advisers's TNON Position: Q3 2023 in Review

RhumbLine Advisers sold out of Tenon Medical (TNON) in Q3 2023, closing a stake of 30 shares — an estimated $652 sold.

RhumbLine Advisers first reported a position in TNON in Q2 2023 and held it in 1 quarter. The position peaked at $652 in Q2 2023. 14 funds tracked by Wall St. Rank hold TNON as of Q3 2023.

  • RhumbLine Advisers reported no remaining Tenon Medical position as of Q3 2023 after selling out during the quarter.
  • RhumbLine Advisers sold 30 Tenon Medical shares in Q3 2023, an estimated $652.
  • RhumbLine Advisers first reported a position in Tenon Medical in Q2 2023 and held it in 1 quarter.
  • RhumbLine Advisers's Tenon Medical position peaked at $652 in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Tenon Medical as of Q3 2023.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.